Effects of Resveratrol on Polycystic Ovary Syndrome: A Double-blind, Randomized, Placebo-controlled Trial.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Polycystic ovary syndrome (PCOS) is the most common endocrinopathy affecting women of reproductive age. Hyperandrogenism is the central feature of PCOS. Studies on isolated ovarian theca-interstitial cells suggest that resveratrol, a natural polyphenol, reduces androgen production.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J. Clin. Endocrinol. Metab.

Title: The Journal of clinical endocrinology and metabolism

Publisher: The Endocrine Society

ISSN (Electronic): 1945-7197

ISSN (Print): 0021-972X

Publication date (Electronic): Nov 2016

Volume: 101

Issue: 11

Affiliations

[1 ] Division of Infertility and Reproductive Endocrinology, Department of Gynecology, Obstetrics and Gynecological Oncology (B.B., J.W.-B., R.Z.S., L.P.), Poznan University of Medical Sciences, 60-535 Poznan, Poland; and Division of Reproductive Endocrinology and Infertility, Department of Reproductive Medicine (A.J.D.), University of California-San Diego, LA Jolla, California, 92093-0633.

Article

DOI: 10.1210/jc.2016-1858

PubMed ID: 27754722

SO-VID: 20a9ce81-c57a-4ba6-86ef-d8add28dc500

History

Data availability:

Comments

Comment on this article

scite_

Cited by 55

See all cited by